Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 4/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.37 |
| ▸ | HPGD | P15428 | 2/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 5/20 | 0.35 |
| ▸ | EGFR | P00533 | 1/20 | 0.35 |
| ▸ | KDR | P35968 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.34 |
| ▸ | GAA | P10253 | 2/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | NPR3 | P17342 | 1/20 | 0.34 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7258056 | 0.88 | ITGB1 (0.43) | NPR3ITGB1ITGA4TACR3 | |
| SCHEMBL7258050 | 0.88 | ITGB1 (0.43) | NPR3ITGB1ITGA4TACR3 | |
| SCHEMBL7105519 | 0.84 | ELANE (0.42) | ELANEMEN1KMT2ANPSR1HPGD | |
| SCHEMBL7105524 | 0.84 | ELANE (0.42) | ELANEMEN1KMT2ANPSR1HPGD | |
| SCHEMBL7716169 | 0.83 | ELANE (0.40) | ELANEMEN1KMT2ANPSR1HPGD | |
| SCHEMBL7716179 | 0.83 | ELANE (0.40) | ELANEMEN1KMT2ANPSR1HPGD | |
| SCHEMBL7714237 | 0.81 | ACP1 (0.36) | MEN1KMT2ANPSR1HPGDPOLB | |
| SCHEMBL7714235 | 0.81 | MAPT (0.36) | MEN1KMT2ANPSR1HPGDPOLB | |
| SCHEMBL7714244 | 0.81 | ACP1 (0.36) | MEN1KMT2ANPSR1HPGDPOLB | |
| SCHEMBL7714207 | 0.79 | ITGB1 (0.42) | ITGB1ITGA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1305291-A1 | 3-SUBSTITUTED ISOQUINOLIN-1-YL DERIVATIVES | Celltech R&D Limited (GB) | 2003-05-02 | — | — | EP | disclosed |
| US-20020177605-A1 | 3-SUBSTITUTED ISOQUINOLIN-1-YL DERIVATIVES | CELLTECH R&D, LTD. (GB) | 2002-11-28 | — | — | US | disclosed |
| US-6469025-B1 | FOR THE PROPHYLAXIS OR TREATMENT OF A DISEASE OR DISORDER IN A MAMMAL IN WHICH THE EXTRAVASATION OF LEUKOCYTES PLAYS A ROLE; INHIBITING THE BINDING OF ALPHA 4 INTEGRINS TO THEIR LIGANDS | CELLTECH R&D LTD. (GB) | 2002-10-22 | — | — | US | disclosed |
| WO-2002010136-A1 | 3-SUBSTITUTED ISOQUINOLIN-1-YL DERIVATIVES | CELLTECH R & D LIMITED (GB) | 2002-02-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020177605-A1 | 3-SUBSTITUTED ISOQUINOLIN-1-YL DERIVATIVES | ICAM1, VCAM1, CCR1 | ELANE 3866/4885MEN1 4668/4885KMT2A 2692/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.